Apimeds Pharmaceuticals US, Inc. (APUS) share price today is $2.78 as of October 27, 2026 at 12:52 AM IST. The stock touched a day high of $3.11 and a day low of $2.72.

Apimeds Pharmaceuticals US, Inc. stock trades on NYSE MKT under the ticker symbol APUS.

Apimeds Pharmaceuticals US, Inc.'s market capitalization is $4.36M as of October 27, 2026 at 12:52 AM IST.

Apimeds Pharmaceuticals US, Inc.'s price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

Apimeds Pharmaceuticals US, Inc.'s price-to-book (P/B) ratio is 0.02 as of October 26, 2026.

Yes, You can buy Apimeds Pharmaceuticals US, Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

Indian investors can buy Apimeds Pharmaceuticals US, Inc. shares in three steps: 1. Search Apimeds Pharmaceuticals US, Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

Since Apimeds Pharmaceuticals US, Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

Indian investors can start investing in Apimeds Pharmaceuticals US, Inc. (APUS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.5945 shares at the current price of $2.78.